Table of Contents 1 Study Coverage 1.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth Rate by Product 1.4.2 Consumables 1.4.3 Services 1.4.4 Software 1.5 Market by End User 1.5.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth Rate by End User 1.5.2 Oncology 1.5.3 Cardiology 1.5.4 Neurology 1.5.5 Other 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size 2.1.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue 2014-2025 2.1.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales 2014-2025 2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Growth Rate by Regions 2.2.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Regions 2.2.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturers 3.1.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturers 3.1.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturers 3.1.3 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Concentration Ratio (CR5 and HHI) 3.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturers 3.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturers (2014-2019) 3.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Manufacturers (2014-2019) 3.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Price by Manufacturers 3.4 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturing Base Distribution, Product Types 3.4.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Type 3.4.3 Date of International Manufacturers Enter into Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Product 4.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Product 4.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Breakdown Data by End User 6 North America 6.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Countries 6.1.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries 6.1.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Product 6.3 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications by End User 7 Europe 7.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Countries 7.1.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries 7.1.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Product 7.3 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications by End User 8 Asia Pacific 8.1 Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Countries 8.1.1 Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries 8.1.2 Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Product 8.3 Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications by End User 9 Central & South America 9.1 Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Countries 9.1.1 Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries 9.1.2 Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Product 9.3 Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications by End User 10 Middle East and Africa 10.1 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Countries 10.1.1 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries 10.1.2 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Product 10.3 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications by End User 11 Company Profiles 11.1 Roche 11.1.1 Roche Company Details 11.1.2 Company Business Overview 11.1.3 Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Products Offered 11.1.5 Roche Recent Development 11.2 Dako (Agilent Technologies) 11.2.1 Dako (Agilent Technologies) Company Details 11.2.2 Company Business Overview 11.2.3 Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Products Offered 11.2.5 Dako (Agilent Technologies) Recent Development 11.3 Merck 11.3.1 Merck Company Details 11.3.2 Company Business Overview 11.3.3 Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Products Offered 11.3.5 Merck Recent Development 11.4 BD 11.4.1 BD Company Details 11.4.2 Company Business Overview 11.4.3 BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Gross Margin (2014-2019) 11.4.4 BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Products Offered 11.4.5 BD Recent Development 11.5 Abbott 11.5.1 Abbott Company Details 11.5.2 Company Business Overview 11.5.3 Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Products Offered 11.5.5 Abbott Recent Development 11.6 Genesys Biolabs (20/20GeneSystems) 11.6.1 Genesys Biolabs (20/20GeneSystems) Company Details 11.6.2 Company Business Overview 11.6.3 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Products Offered 11.6.5 Genesys Biolabs (20/20GeneSystems) Recent Development 11.7 Affymetrix 11.7.1 Affymetrix Company Details 11.7.2 Company Business Overview 11.7.3 Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Products Offered 11.7.5 Affymetrix Recent Development 11.8 Agendia 11.8.1 Agendia Company Details 11.8.2 Company Business Overview 11.8.3 Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Gross Margin (2014-2019) 11.8.4 Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Products Offered 11.8.5 Agendia Recent Development 11.9 ALMAC 11.9.1 ALMAC Company Details 11.9.2 Company Business Overview 11.9.3 ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Gross Margin (2014-2019) 11.9.4 ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Products Offered 11.9.5 ALMAC Recent Development 11.10 Arrayit 11.10.1 Arrayit Company Details 11.10.2 Company Business Overview 11.10.3 Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Gross Margin (2014-2019) 11.10.4 Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Products Offered 11.10.5 Arrayit Recent Development 11.11 Biocartic 11.12 BG Medicine 11.13 KEGG EXPRESSION Database 11.14 Thermo Fisher 11.15 BGI 12 Future Forecast 12.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast by Regions 12.1.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Forecast by Regions 2019-2025 12.1.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Forecast by Regions 2019-2025 12.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast by Product 12.2.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Forecast by Product 2019-2025 12.2.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Forecast by Product 2019-2025 12.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast by End User 12.4 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast 12.5 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast 12.6 Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast 12.7 Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast 12.8 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Picture Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Segments Table Key Manufacturers Commercializing Biomarkers in Therapeutic and Diagnostic Applications Covered Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$) Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Product 2014-2025 Figure Consumables Product Picture Table Major Manufacturers of Consumables Figure Services Product Picture Table Major Manufacturers of Services Figure Software Product Picture Table Major Manufacturers of Software Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth Rate by End User 2019-2025 (K Units) Figure Oncology Figure Cardiology Figure Neurology Figure Other Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Report Years Considered Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size 2014-2025 (Million US$) Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales 2014-2025 (K Units) Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Regions 2014-2019 (K Units) Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Regions 2014-2019 Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Regions 2014-2019 Figure 2018 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Regions Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Regions 2014-2019 (Million US$) Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Regions 2014-2019 Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Regions 2014-2019 Figure 2018 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Regions Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturers (2014-2019) (K Units) Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Manufacturers (2014-2019) Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturers (2014-2019) (Million USD) Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Manufacturers (2014-2019) Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Value Share by Manufacturers in 2018 Table Key Manufacturers Commercializing Biomarkers in Therapeutic and Diagnostic Applications Price (2014-2019) (USD/Unit) Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Type Table Date of International Manufacturers Enter into Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Product (2014-2019) (K Units) Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Product (2014-2019) Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Product (2014-2019) Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Product in 2018 Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Product (2014-2019) (Million US$) Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Product (2014-2019) Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Product (2014-2019) Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Product in 2018 Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Price by Product 2014-2019 (USD/Unit) Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by End User (2014-2019) (K Units) Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by End User (2014-2019) Figure Global Sales Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by End User (2014-2019) Figure Global Sales Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by End User in 2018 Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate 2014-2019 (K Units) Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate 2014-2019 (Million US$) Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2014-2019) (K Units) Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2014-2019) Figure 2018 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2014-2019) (Million US$) Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries (2014-2019) Figure 2018 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries Figure United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (K Units) Figure Canada Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure Canada Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure Mexico Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Product (2014-2019) (K Units) Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Product (2014-2019) Figure 2018 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Product Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by End User (2014-2019) (K Units) Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by End User (2014-2019) Figure 2018 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by End User Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate 2014-2019 (K Units) Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate 2014-2019 (Million US$) Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2014-2019) (K Units) Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2014-2019) Figure 2018 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2014-2019) (Million US$) Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries Figure Germany Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure Germany Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Figure France Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure France Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Figure UK Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure UK Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure Italy Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure Russia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Product (2014-2019) (K Units) Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Product (2014-2019) Figure 2018 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Product Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by End User (2014-2019) (K Units) Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by End User (2014-2019) Figure 2018 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by End User Figure Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2014-2019) (K Units) Table Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries Table Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries Figure China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure Korea Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Figure India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure Australia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure Indonesia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure Malaysia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure Philippines Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure Thailand Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure Vietnam Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure Singapore Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Product (2014-2019) (K Units) Table Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Product Table Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by End User (2014-2019) (K Units) Table Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by End User Figure Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate 2014-2019 (K Units) Figure Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2014-2019) (K Units) Table Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries Table Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2014-2019) (Million US$) Table Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries Figure Brazil Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure Brazil Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure Argentina Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Product (2014-2019) (K Units) Table Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Product Table Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by End User (2014-2019) (K Units) Table Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by End User Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2014-2019) (K Units) Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries Figure GCC Countries Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure Turkey Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure Egypt Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate (2014-2019) (K Units) Figure South Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Product (2014-2019) (K Units) Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Product Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by End User (2014-2019) (K Units) Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by End User Table Roche Company Details Table Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Roche Recent Development Table Dako (Agilent Technologies) Company Details Table Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Dako (Agilent Technologies) Recent Development Table Merck Company Details Table Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Merck Recent Development Table BD Company Details Table BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table BD Recent Development Table Abbott Company Details Table Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Abbott Recent Development Table Genesys Biolabs (20/20GeneSystems) Company Details Table Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Genesys Biolabs (20/20GeneSystems) Recent Development Table Affymetrix Company Details Table Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Affymetrix Recent Development Table Agendia Company Details Table Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Agendia Recent Development Table ALMAC Company Details Table ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table ALMAC Recent Development Table Arrayit Company Details Table Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Arrayit Recent Development Table Biocartic Company Details Table BG Medicine Company Details Table KEGG EXPRESSION Database Company Details Table Thermo Fisher Company Details Table BGI Company Details Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Forecast by Regions 2019-2025 (K Units) Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share Forecast by Regions 2019-2025 Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share Forecast by Regions 2019-2025 Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Forecast by Product 2019-2025 (K Units) Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share Forecast by Product 2019-2025 Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Forecast by Product 2019-2025 (Million US$) Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share Forecast by Product 2019-2025 Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Forecast by End User 2019-2025 (K Units) Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share Forecast by End User 2019-2025 Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Value Chain Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Customers List Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Roche Dako (Agilent Technologies) Merck BD Abbott Genesys Biolabs (20/20GeneSystems) Affymetrix Agendia ALMAC Arrayit Biocartic BG Medicine KEGG EXPRESSION Database Thermo Fisher BGI